Both Ets1 and Ets2 expression are correlated with decreased disease-free survival in breast cancer patients and a dominant negative Ets construct can inhibit the anchorage independent growth of breast cancer cell lines [12], [13]. This evidence concerns the gene ETS2 and breast cancer.